The role of macrophages in Docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC).

Lisa G. Horvath, Mark D. Chatfield, Michelle Lee-Ng, Hui-Ming Lin, Lesley Castillo, Samuel N. Breit, David A. Brown, Mark P. Molloy, Gavin M. Marx, Nick Pavlakis, Michael J. Boyer, Martin R. Stockier, Richard Wykes, Susan M. Henshall, Kate Lynette Mahon

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)1-1
Number of pages1
JournalJournal of Clinical Oncology
Volume31
Issue number15_suppl
DOIs
Publication statusPublished - 20 May 2013
EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
Duration: 31 May 20134 Jun 2013

Cite this

Horvath, L. G., Chatfield, M. D., Lee-Ng, M., Lin, H-M., Castillo, L., Breit, S. N., ... Mahon, K. L. (2013). The role of macrophages in Docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC). Journal of Clinical Oncology, 31(15_suppl), 1-1. https://doi.org/10.1200/jco.2013.31.15_suppl.e22175